|
Volumn 17, Issue 14, 2003, Pages 2160-2162
|
Imatinib induces mitochondria-dependent apoptosis of the Bcr-Abl-positive K562 cell line and its differentiation toward the erythroid lineage.
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ABELSON KINASE;
ANTINEOPLASTIC AGENT;
BCR ABL PROTEIN;
ENZYME INHIBITOR;
IMATINIB;
PIPERAZINE DERIVATIVE;
PYRIMIDINE DERIVATIVE;
APOPTOSIS;
ARTICLE;
BIOLOGICAL MODEL;
CELL DIFFERENTIATION;
CELL LINEAGE;
CELL STRAIN K 562;
CHRONIC MYELOID LEUKEMIA;
DNA MICROARRAY;
DRUG ANTAGONISM;
DRUG EFFECT;
ERYTHROID PRECURSOR CELL;
GENETICS;
HUMAN;
METABOLISM;
MITOCHONDRION;
PATHOLOGY;
PHOSPHORYLATION;
PHYSIOLOGY;
SIGNAL TRANSDUCTION;
ANTINEOPLASTIC AGENTS;
APOPTOSIS;
CELL DIFFERENTIATION;
CELL LINEAGE;
ENZYME INHIBITORS;
ERYTHROID PROGENITOR CELLS;
FUSION PROTEINS, BCR-ABL;
HUMANS;
K562 CELLS;
LEUKEMIA, MYELOID, CHRONIC;
MITOCHONDRIA;
MODELS, BIOLOGICAL;
OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS;
PHOSPHORYLATION;
PIPERAZINES;
PROTO-ONCOGENE PROTEINS C-ABL;
PYRIMIDINES;
SIGNAL TRANSDUCTION;
|
EID: 0642303647
PISSN: None
EISSN: 15306860
Source Type: Journal
DOI: 10.1096/fj.03-0322fje Document Type: Article |
Times cited : (110)
|
References (0)
|